Home » Topics » Regulatory » Patents

Patents
RSS

Egis prepares new AMPA receptor antagonists

Dec. 8, 1997

Analgesics under evaluation at Ortho

Dec. 8, 1997

Structurally distinct class of 5-HT1B antagonists prepared at SmithKline Beecham

Dec. 8, 1997

Alcon compounds with dual antioxidant/cysteine prodrug properties

Dec. 8, 1997

Endothelin-modulating compounds developed at Texas Biotechnology

Dec. 5, 1997

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

Bayer develops CETP inhibitors

Dec. 4, 1997

Diagnostic use of specific sigma2 ligands described by Wake Forest University

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...